Reduced expression of autotaxin predicts survival in uveal melanoma
暂无分享,去创建一个
G. Casey | Yaomin Xu | P. Kessler | Arun D. Singh | I. Rennie | K. Sisley | S. Plummer | Jianbo Li | P. Faber | H. Mudhar | Bryan R. G. Williams | Bryan R. G. Williams
[1] E. Antecka,et al. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study , 2007, Eye.
[2] Arie Perry,et al. Transcriptomic versus Chromosomal Prognostic Markers and Clinical Outcome in Uveal Melanoma , 2007, Clinical Cancer Research.
[3] Y. Kishi,et al. Autotaxin Is Overexpressed in Glioblastoma Multiforme and Contributes to Cell Motility of Glioblastoma by Converting Lysophosphatidylcholine TO Lysophosphatidic Acid* , 2006, Journal of Biological Chemistry.
[4] Justis P. Ehlers,et al. Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. , 2006, Cancer research.
[5] D. Edwards,et al. Metalloproteinases and their inhibitors in tumor angiogenesis , 2005, International journal of cancer.
[6] M. Bollen,et al. Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D , 2005, Journal of Cell Science.
[7] M. Herlyn,et al. Adhesion, migration and communication in melanocytes and melanoma. , 2005, Pigment cell research.
[8] A. Reeve,et al. A gene expression signature for relapse of primary wilms tumors. , 2005, Cancer research.
[9] Arun D. Singh,et al. Uveal melanoma: epidemiologic aspects. , 2005, Ophthalmology clinics of North America.
[10] B. Williams,et al. Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia , 2005, Oncogene.
[11] Justis P. Ehlers,et al. Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death , 2004, Cancer Research.
[12] G. Mills,et al. Lysophosphatidic acid production and action: Validated targets in cancer? , 2004, Journal of cellular biochemistry.
[13] B. Giepmans,et al. The ins and outs of lysophosphatidic acid signaling , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.
[14] H. Dralle,et al. Expression, regulation and function of autotaxin in thyroid carcinomas , 2004, International journal of cancer.
[15] R. Frants,et al. Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development , 2003, British Journal of Cancer.
[16] T. Kivelä,et al. Very long-term prognosis of patients with malignant uveal melanoma. , 2003, Investigative ophthalmology & visual science.
[17] C. Shields. Incidence of Uveal Melanoma in the United States: 1973–1997 , 2003 .
[18] S. Pavey,et al. Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development , 2003, International journal of cancer.
[19] Eric R. Ziegel,et al. The Elements of Statistical Learning , 2003, Technometrics.
[20] K. Jöckel,et al. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. , 2003, Cancer research.
[21] Arun D. Singh,et al. Incidence of uveal melanoma in the United States: 1973-1997. , 2003, Ophthalmology.
[22] Arun D. Singh,et al. Survival rates with uveal melanoma in the United States: 1973-1997. , 2003, Ophthalmology.
[23] Tala Bakheet,et al. p38 Mitogen-Activated Protein Kinase-Dependent and -Independent Signaling of mRNA Stability of AU-Rich Element-Containing Transcripts , 2003, Molecular and Cellular Biology.
[24] Hyun Cheol Chung,et al. Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells , 2002, Clinical & Experimental Metastasis.
[25] G. Mills,et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.
[26] R. Kiessling,et al. HLA expression in uveal melanoma: there is no rule without some exception. , 2002, Human immunology.
[27] J. Earle,et al. THE COMS RANDOMIZED TRIAL OF IODINE 125 BRACHYTHERAPY FOR CHOROIDAL MELANOMA, III: INITIAL MORTALITY FINDINGS COMS REPORT NO. 18 , 2002 .
[28] Y. S. Kim,et al. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. , 2001, Cancer research.
[29] A. Tarkkanen,et al. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. , 2001, Investigative ophthalmology & visual science.
[30] C. Shields,et al. Prognostic factors in uveal melanoma , 2001, Melanoma research.
[31] G. Mann,et al. Responses to ultraviolet-B in cell lines from hereditary melanoma kindreds , 2001, Melanoma research.
[32] F. Marincola,et al. High-fidelity mRNA amplification for gene profiling , 2000, Nature Biotechnology.
[33] M. Tsao,et al. Autotaxin expression in non-small-cell lung cancer. , 1999, American journal of respiratory cell and molecular biology.
[34] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] Jennifer I. Lim,et al. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10. , 1998, American journal of ophthalmology.
[36] V. Kähäri,et al. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. , 1998, Cancer research.
[37] M. Hendrix,et al. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[38] R. Rees,et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis , 1997, Genes, chromosomes & cancer.
[39] I. McLean,et al. Uveal melanoma , 1997, Cancer.
[40] N. Bornfeld,et al. Prognostic implications of monosomy 3 in uveal melanoma , 1996, The Lancet.
[41] C. Shields,et al. Cytogenetic findings in primary uveal melanoma. , 1994, Cancer genetics and cytogenetics.
[42] R. Folberg,et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. , 1993, Ophthalmology.
[43] R. Folberg,et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. , 1992, Human pathology.
[44] H. Krutzsch,et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.
[45] B. Hawkins,et al. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. , 1992, Archives of ophthalmology.
[46] N. Bornfeld,et al. Nonrandom chromosomal abnormalities in primary uveal melanoma. , 1990, Journal of the National Cancer Institute.
[47] Arun D. Singh,et al. CHAPTER 35 – Uveal malignant melanoma: epidemiologic aspects , 2007 .
[48] S. Fine. Collaborative ocular melanoma study group. , 1999, Archives of family medicine.
[49] B. Melia,et al. Mortality in patients with small choroidal melanoma the collaborative ocular melanoma study-group members of the writing team, who signed authorship responsibility, financial disclosure, and copyright transfer statements for the group are as follows , 1997 .
[50] Mortality in patients with small choroidal melanoma. COMS report no. 4. The Collaborative Ocular Melanoma Study Group. , 1997, Archives of ophthalmology.
[51] C. Shields,et al. Clinical genetics of retinoblastoma. , 1993, International ophthalmology clinics.
[52] Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1. , 1990, Archives of ophthalmology.
[53] R. Glynn,et al. Epidemiologic aspects of uveal melanoma. , 1988, Survey of ophthalmology.